Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NOSTRIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SPC25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
G6PC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABCB11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CERS6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DHRS9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK39 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B3GALT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XIRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCN7A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on